SEC11C

Across TCGA pan-cancer cohorts, SEC11C Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated SEC11C data layer compared with 26 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher SEC11C Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated SEC11C expression acts as an unfavorable survival marker.

LIHC and LGG are the cancer types where SEC11C Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Median	All	0.076	0.553	.002	24	view →
LGG	OS	Median	All	0.306	0.799	.009	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

SEC11C–LIHC (DFS)

Open the LIHC breakdown →